Ken Griffin My Md Pharmaceuticals, Inc. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$0.22 - $0.58 $8,910 - $23,490	-40,500 Reduced 53.86%	34,700 $9,000
Q3 2023 Nov 14, 2023	BUY	$0.47 - $1.87 $2,491 - $9,911	5,300 Added 7.58%	75,200 $44,000
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.26 $50,544 - $79,325	35,100 Added 100.86%	69,900 $104,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.86 $1,760 - $4,576	1,600 Added 4.82%	34,800 $59,000
Q4 2022 Feb 14, 2023	SELL	$0.92 - $96.0 $12,512 - $1.31 Million	-13,600 Reduced 29.06%	33,200 $38,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $103,896 - $3.85 Million	46,800 New	46,800 $122,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.